Stockscreener 앱 받기
8.05
2.78%
-0.23
시간 외 거래:
8.07
0.02
+0.25%
Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스
DiaMedica Therapeutics (DMAC) price target increased by 25.68% to 15.81 - MSN
Can DiaMedica Therapeutics Inc. stock surprise with earnings upsideTrade Analysis Summary & Growth Focused Stock Pick Reports - Улправда
DiaMedica Therapeutics provides DM199 update following FDA meeting - MSN
Why DiaMedica Therapeutics Inc. stock attracts high net worth investorsGold Moves & Low Volatility Stock Suggestions - Улправда
Is DiaMedica Therapeutics Inc. stock in correction or buying zone2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - Улправда
Aug Big Picture: Why DiaMedica Therapeutics Inc. stock is a value investor pickInsider Selling & Weekly Watchlist for Hot Stocks - Улправда
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers - Nasdaq
DiaMedica (DMAC) Advances with FDA in Preeclampsia Study Plans - GuruFocus
DiaMedica Says FDA Seeks Additional Study Ahead of Pre-IND Submission for Preeclampsia Treatment - marketscreener.com
DiaMedica to conduct additional study for preeclampsia treatment - Investing.com
DiaMedica to conduct additional study for preeclampsia treatment By Investing.com - Investing.com Canada
Diamedica Therapeutics provides DM199 preeclampsia program update - marketscreener.com
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting - TipRanks
DiaMedica Therapeutics Inc Provides DM199 Preeclampsia Program Update - TradingView — Track All Markets
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA - The AI Journal
[8-K] DiaMedica Therapeutics Inc. Reports Material Event | DMAC SEC FilingForm 8-K - Stock Titan
A US$59m Drop in the Market Cap of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Is Not What Insiders Like to See After Purchasing Shares Recently - 富途牛牛
DiaMedica Therapeutics Earnings Notes - Trefis
DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 7.4%Here's Why - MarketBeat
DiaMedica Therapeutics Inc (DMAC) Stock News & Articles - 24/7 Wall St.
Top investors say DiaMedica Therapeutics Inc (DMAC) ticks everything they need - setenews.com
DiaMedica Therapeutics (NASDAQ:DMAC) Sets New 1-Year HighTime to Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Diamedica Therapeutics (DMAC) - The Globe and Mail
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Purchases 182,882 Shares of Stock - Defense World
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Buys 187,393 Shares of Stock - Defense World
Jan Stahlberg Acquires 208,872 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,234,453.50 in Stock - MarketBeat
Insider Buying: DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Purchases 128,426 Shares of Stock - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Purchases 40,253 Shares - MarketBeat
What dividend safety score for DiaMedica Therapeutics Inc. stock2025 Risk Factors & Fast Gain Stock Tips - Newser
What drives DiaMedica Therapeutics Inc stock priceAnalyst Downgrades & Free Lightning Fast Capital Gains - earlytimes.in
We Think DiaMedica Therapeutics (NASDAQ:DMAC) Can Afford To Drive Business Growth - Yahoo Finance
Private Capital's DiaMedica Therapeutics Inc(DMAC) Holding History - GuruFocus
Why DiaMedica Therapeutics Inc. stock is a value investor pickJuly 2025 Drop Watch & Smart Allocation Stock Tips - moha.gov.vn
There is no way DiaMedica Therapeutics Inc (DMAC) can keep these numbers up - setenews.com
Dir Parsons Acquires 12,000 Of DiaMedica Therapeutics Inc [DMAC] - TradingView
[Form 4] DiaMedica Therapeutics Inc. Insider Trading Activity - Stock Titan
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
DiaMedica In Focus After 52-Week High And FDA Meeting Progress - RTTNews
How DiaMedica Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double - inkl
HC Wainwright Has Bearish Forecast for DMAC FY2025 Earnings - Defense World
Smart tools for monitoring DiaMedica Therapeutics Inc.’s price actionPortfolio Value Summary & Growth Focused Stock Pick Reports - newser.com
Why analysts remain bullish on DiaMedica Therapeutics Inc. stock2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Published on: 2025-11-19 22:42:15 - newser.com
0.23%
0.08%
자본화:
|
볼륨(24시간):